Search is Powered by Google
Veterinary News

IMULAN Creates Clinical Website For Veterinarians

Main Category: Veterinary
Article Date: 08 Oct 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Imulan BioTherapeutics, LLC (IMULAN) announced they have launched a new clinical trial website, http://www.IMULANtrials.com, to accommodate their growing comparative research and clinical trial program. The new website will provide veterinarians information regarding IMULAN's ongoing and future trials, including trials for atopic dermatitis, feline stomatitis, asthma, leukemia virus, and other diseases associated with infections or immune mediated disorders.

About the Technologies

Imulan is developing three immune regulating technologies for veterinary medicine, being LTCI, ImSAIDs, and TCR Vax.

LTCI: Lymphocyte T-Cell Immunomodulator is a biologic that has received a conditional license as a treatment aid for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) infections and their associated symptoms including opportunistic infection and anemia.

ImSAIDs: The Immune Selective Anti-Inflammatory Derivatives are rapidly acting, orally active natural biological peptides that are being investigated for their use in controlling inappropriate immune responses associated with sepsis, anaphylaxis, acute trauma, pancreatitis, cystitis, allergies and asthma.

TCR Vax: T-Cell Receptor Peptide Vaccines modulate T-helper cell responses, including restoring immune function in aged animals and restoring Th1/Th2 cytokine signaling profiles. TCR Vax is a lead candidate for canine atopic dermatitis and has recently shown promise in feline stomatitis.

About Imulan

Imulan develops unique, precision immune regulating compounds for veterinary medicine. Imulan's primary focus is on biological strategies that combine peptide pharmacology with immunology to treat infectious, autoimmune, and immune mediated diseases in small and large animal medicine. IMULAN recently commercialized Lymphocyte T-Cell Immunomodulator as a conditionally licensed treatment aid for cats infected with feline leukemia and immunodeficiency virus.

Imulan




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Saving Lives with the Help of Machines
Saving Lives with the Help of Machines

An automated external defibrillator - or A-E-D - places the technology of the emergency room into the hands of everyday people.

more videos are available in our health videos section.